Table 3

Toxicity of treatment in the 19 evaluable patients

No. of patients
Hematologic toxicity (grade 3-4 WHO)  
    Neutropenia/thrombocytopenia/anemia 0/0/1 
Hematologic toxicity (grade 1-2 WHO)  
    Neutropenia/thrombocytopenia/anemia 1/1/1 
Extrahematologic toxicity (grade 3-4 WHO)  
    Pneumonia 
    CNS viral infection (JCV) 
    Pleural effusion 
    Hydric retention/edema 
Extrahematologic toxicity (grade 1-2 WHO)  
    Gastroenteric/liver 0/0 
    Kidney/neurologic 0/0 
    Cardiovascular 
    Hydric retention/edema 
    Nausea or vomiting 
Stop imatinib (causes)  
    Yes/no 8/11 
    No response of cGVHD 
    Relapse of underlying disease requiring new treatment 
    Hydric retention* 
    CNS viral infection (JCV) 
No. of patients
Hematologic toxicity (grade 3-4 WHO)  
    Neutropenia/thrombocytopenia/anemia 0/0/1 
Hematologic toxicity (grade 1-2 WHO)  
    Neutropenia/thrombocytopenia/anemia 1/1/1 
Extrahematologic toxicity (grade 3-4 WHO)  
    Pneumonia 
    CNS viral infection (JCV) 
    Pleural effusion 
    Hydric retention/edema 
Extrahematologic toxicity (grade 1-2 WHO)  
    Gastroenteric/liver 0/0 
    Kidney/neurologic 0/0 
    Cardiovascular 
    Hydric retention/edema 
    Nausea or vomiting 
Stop imatinib (causes)  
    Yes/no 8/11 
    No response of cGVHD 
    Relapse of underlying disease requiring new treatment 
    Hydric retention* 
    CNS viral infection (JCV) 

WHO indicates World Health Organization; CNS, central nervous system; JCV, John Cunningham virus; and cGVHD, chronic graft-versus-host disease.

*

Dead.

Close Modal

or Create an Account

Close Modal
Close Modal